Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Three SS-OCT and One PCI Optical Biometers in Eyes With Dense Cataract: Benefit of Use of the Enhance Retina Visualization Mode

NCT05239715 is registered in ClinicalTrials.gov with OFTALVIST (Oftalmología Vistahermosa S.L) as lead sponsor.

NCT NCT05239715
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05239715 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Three SS-OCT and One PCI Optical Biometers in Eyes With Dense Cataract: Benefit of Use of the Enhance Retina Visualization Mode
Lead sponsor
OFTALVIST (Oftalmología Vistahermosa S.L)
Phase
Observational
Overall status
Completed
Start date
February 10, 2022
Completion date
October 31, 2022
Enrollment
51 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

optical biometer, cataracts